CellAegis Devices offers autoRIC, an automated non-invasive device that provides point-of-care delivery of remote ischemic conditioning. The autoRIC Device is intended to provide remote ischemic conditioning to adult patients over 18 years of age undergoing cardiothoracic surgery or interventional cardiothoracic procedures or patients with evolving myocardial infarction. The autoRIC Device is highly portable and time‐efficient, delivering four cycles of simple‐to-administer treatment in less than 40 minutes, freeing up valuable healthcare resources. Device operation is simple and compatible with current standard‐of‐care treatments. RIC delivery is consistent, reliable, and cost-effective.
|Employees (est.) (Aug 2020)||6|
CellAegis Devices total Funding
CellAegis Devices latest funding size
Time since last funding
|4 years ago|
CellAegis Devices investors
|Broadview Ventures, CTI Life Sciences Fund, MaRS Catalyst Fund|
Who are CellAegis Devices key executives?
CellAegis Devices's key executives are Rocky Ganske, Brian Fielding and Vera Belaoussoff.
How many employees does CellAegis Devices have?
CellAegis Devices has 6 employees.
Who are CellAegis Devices competitors?
Competitors of CellAegis Devices include Inspire Living, Enzyre and Cardionomic.
Where are CellAegis Devices offices?
CellAegis Devices has offices in Palo Alto and Mississauga.
How many offices does CellAegis Devices have?
CellAegis Devices has 3 offices.
Receive alerts for 300+ data fields across thousands of companies